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Abstract: An 8-year-old boy was seen with a cutaneous Ki-1 anaplastic, 
large cell lymphoma with multiple lesions. Some of the lesions showed 
spontaneous regression. During more than seven years of disease no 
systemic involvement was observed, but recurrent, self-heal~ng lesions 
did appear. Histopathologic examination of five lesions revealed a variety 
of findings, from an inflammatory infiltrate to a highly anaplastic pattern. 
The neoplastic cells expressed Ki-1 and leukocyte common antigens. UI- 
trastructurally, those cells showed ruffled indentations. The diffe~ntial 
diagnosis includes microvillous malignant lymphoma. The patient has 
had a four-year follow-up without relapses. 
In 1985 Stein et a1 (1) described an anaplastic 
large cell lymphoma (ALCL) that expressed a 
Hodgkin disease-associated antigen, Ki-1 , an entity 
previously misdiagnosed as malignant histiocytosis 
or anaplastic carcinoma. The Ki-1 ALCL expresses 
T cell or, less frequently, B cell antigens, although 
occasionally neither antigen is expressed. Since 
that first description, approximately 170 cases have 
been published (2-21), half of which occurred in 
children (2,4,5,7,9,11,13,15,16,20). 
Peripheral lymph nodes constitute the most fre- 
quent primary site of the tumor, but the skin, medi- 
astinal lymph nodes, and stomach may also be in- 
volved in initial disease. The prognosis is more 
favorable when the skin is the primary site (3,ll- 
14,18). The cutaneous lesions are represented by 
solitary or multiple nodules and, less frequently, in- 
filtrated plaques or tumors. In 1986 Kadin et a1 (1 1) 
described six children with Ki-1 ALCL with periph- 
eral lymphadenopathy, three of whom had regress- 
ing skin nodules. Follow-up was limited, however, 
and biopsies were performed in just one lesion from 
each patient. 
We cared for a child with cutaneous Ki-1 ALCL 
with regressing skin lesions for seven years. Histo- 
pathologic examination was performed on five le- 
sions representing different stages of development. 
CASE REPORT 
A 6-year-old boy was admitted in July 1987 with a 
four-year history of spontaneously regressing cuta- 
neous nodules on the abdomen. Two months before 
admission three new lesions had appeared in the 
same area, two of which had gradually increased in 
size and shown no evidence of involution. The child 
had no other complaints. The only remarkable 
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Figure 1. Two lesions, one surgical scar, and many 
small hyperchromic scars corresponding to involuted 
lesions. 
physical findings were three a ~ o m ~ n a ~  odules 
with a scaly, erythematous surface, measuring 3.3 
x 3.3  cm, 2.0 x 2.0 cm, and 0.7 x 0.7 cm, respec- 
tively (Fig. I ) .  Slightly depressed scars were seen 
on the surrounding skin. Physical examination re- 
vealed no other abnormalities. 
The larger lesion was excised and a diagnosis of 
matignant fibrous histiocytoma was made. After 
this diagnosis the other two lesions were completely 
excised. Laboratory findings, bone marrow rnor- 
phology , and a chest roentgenogram were unre- 
markable. N o  therapy was undertaken. 
Ten months later the patient had a relapse on the 
surgical scar of the larger nodule that did not re- 
gress. At this time clinical and laboratory evalua- 
tion showed no other abnormalities. The lesion was 
excised and submitted for histopathologic study. 
Due to the diagnosis of Ki-1 ALCL, the patient un- 
derwent chemotherapy according to the LSA2-L2 
protocol (22) as follows: induction phase-intrave- 
nous cyclophosphamide with radiation therapy, 
prednisone plus vincristine, intrathecal methotrex- 
ate, and intravenous daunomycin; consolidation 
phase-~ntra~enous cytosine arabinoside and oral 
th~oguanjne, i~~ravenous  L-asparaginase, intrathe- 
cal methotrexate, and intravenous BCNU [1,3- 
bis(2-chloroethyl)-l-nitrosourea]; and maintenance 
phase-five-day cycles of ~hiog~anine,  cyclophos- 
phamide, hydroxyurea, daunomycin, methotrexate, 
BCN U , arabinosylcytosine, and vincristine fol- 
lowed by intrathecal methotrexate. This regimen 
continued for one year. Two weeks prior to conclu- 
sion of treatment the child developed five erythem- 
atous, papuionodular lesions on the chest, measur- 
ing from I .O to 0.2 cm, that disappeared completely 
in a few weeks. One of those lesions was excised 
and submitted for his to~atho~og~c examination. No 
other lesions developed. At the tast evaluation in 
September 1991, no other abnormalities were ob- 
served. 
LABORATORY STUDIES 
Formalin-fixed tissue was processed routinely, em- 
bedded in paraffin, and stained with hematoxylin 
and eosin. 
Histopathologic Studies 
The histologic appearance of the three initial lesions 
was not uniform. The largest lesion exhibited an ex- 
tensive pieomorphic infiltrate entirely replacing the 
dermis and subcutis. The infiltrate was predomi- 
nantly composed of large, highly atypical, mononu- 
clear and polynuciear cells with marked nuclear 
atypia and an abundant amphophilic cytoplasm 
(Fig, 2). Frequently the nuclei were indented and 
eccentrically placed in the cytoplasm, which had a 
prominent paranuclear halo. MuItinucleated cells 
were present, some of which exhibited horseshoe 
and wreathlike disposition of nuclei. Chromatin 
tended to be granular and evenly distributed. As 
prominent nucleolus was generally observed. Mi- 
totic figures, including atypical figures, were very 
common. 
The medium-size lesion showed a diffuse infiltra- 
tion replacing the dermis and part of the subcutis. 
The infiltrate was composed of smalf ~ymphocyte~, 
histiocytes, polymorphonuclear leukocytes, and 
many mononuclear and polynuclear atypical cells 
with frequent mitosis. Cellular p I e ~ m ~ ~ h i s m  was 
less marked. 
Figure 2, Large mononuclear cells with oval or reni- 
form nuclei with prominent nucleoli and abundant cy- 
toptasm. ~~ematoxylin & eosin; magnificatio~ 400x .) 
Bittencourt et al: Ki-1 Large Cell Lymphoma 119 
TABLE 1. Panel of Antibodies 
Figure 3. Section from the recurrent lesion. At left is a 
highly anaplastic infiltration with giant cells; at right 
are cohesive neoplastic cells with pale-staining mac- 
rophages among them. (Hematoxylin & eosin; magni- 
fication 160x.) 
The smaller lesion had a benign appearance, con- 
sisting of a diffuse infiltrate, with small lympho- 
cytes and histiocytes replacing the dermis and the 
superficial part of the subcutis. Granulation-like tis- 
sue was observed on the superficial part of the le- 
sion. Areas of hemorrhage and fibrosis were also 
seen. 
The recurrent lesion was the most pleomo~hic.  
It was almost entirely composed of pleomorphic 
cells with abundant eosinophilic cytoplasm. The 
neoplastic cells at the edge of the lesion in the sub- 
cutis appeared cohesive and had pale-staining mac- 
rophages among them, imparting a “starry-sky” 
pattern (Fig. 3 ) .  Giant tumor cells and mitosis were 
frequently seen. Infiltration by polymorphonuclear 
leukocytes was present only in small foci. Sparse 
binucleated cells resembling Reed-Sternberg cells 
were also observed. In all lesions the epidermis 
showed mild to moderate acanthosis, but no epider- 
motropism of neoplastic cells was observed. The 
last biopsied lesion showed an inflammatory infil- 
trate only. 
Immunohistochemical Studies 
Formalin-fixed and para~n-embedded sections of 
the first large nodule were immunostained using 
commercially available antibodies (Table 1) and 
the avidin-biotin immunoperoxidase method (20). 
Biotinolated horse antimouse antibody and avidin- 
biotin peroxidase complex reagents were obtained 
from Vector Laboratories (Burlington, CA). Sec- 
tions of the recurrent lesion were also tested with 
leukocyte common antigen (LCA) and HAM-56. 


































D = Dako Corporation; BI) = Beckton Dickson; E = Enzodi- 
agnostiks. 
all the neoplastic cells (Fig. 4). The other antibodies 
were negative. 
Ultrastructural Studies 
Small skin samples were immediately immersed in 
2% glutaraldehyde in 0.f M sodium cacodylate 
buffer, pH 7.3, at 4°C for one hour. Postfixation was 
in 1% osmium tetroxide in 0.15 M sodium cacodyl- 
ate buffer, pH 7.3, at 4°C for one hour. Dehydration 
was performed in graded acetone. Tissue fragments 
were included in Epon 812 resin. Blocks were 
trimmed and semithin sections were stained with 
azur 11-toluidine blue. Ultrathin sections were con- 
trasted with uranyl acetate and lead citrate. Sec- 
tions were evaluated using a transmission electron 
microscope (Zeiss model EM-109) at 50 kV. 
Figure 4. Ki-1-positive anaplastic cells (anti-Ki-1 paraf- 
fin section, immunoperoxidase procedure). (Magnifi- 
cation 400x.) 
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The neoplastic cells had abundant cytoplasm 
with many polyribosomes, few profiles of rough 
endoplasmic reticulum, variable numbers of mito- 
chondria, and a small Golgi apparatus. Few neo- 
plastic cells showed lysosomes. The cells fre- 
quently exhibited short cytoplasmic processes (Fig. 
5 )  that occasionally interdigitated with other similar 
cells. The nuclei showed great variation in size and 
shape; sometimes nuclear indentations were 
present. The heterochromatin was usually present 
as a narrow rim adjacent to the inner nuclear mem- 
brane. One or two prominent nucleoli were present 
in the neoplastic cells. Frequently, atypical mitotic 
figures were seen. Phagocytosis of dead cells by 
macrophage-like cells was observed. 
DISCUSSION 
This patient had a primary cutaneous Ki-1 ALCL 
with an indolent clinical course characterized by re- 
gression of the lesions and a seven-year evolution 
without involvement of other organs. 
A similar clinicopathologic picture was described 
in 1982 as regressing atypical histiocytosis (23). Up 
to now 1 1  cases of this entity have been described in 
the literature (24,25). Immunologic phenotyping 
and rearrangement of T cell receptor and chain 
genes suggested that regressing atypical histiocyto- 
sis represents an ALCL (26). In our patient the pos- 
itivity of this tumor for LCA and Ki-1 antigens, and 
the lack of immunoreactivity for HAM-56, a histio- 
cytic marker, permitted the differential diagnosis of 
regressing atypical histiocytosis and malignant his- 
tiocytosis. 
Figure 5. Electron microscopy demonstrates a cell 
with ruffled cytoplasmic membrane and indented nu- 
cieus. (Magnification 12,OOOx.) 
Because of the presence of Reed-Sternberg-like 
cells in Ki-1 ALCL, the differential diagnosis with 
Hodgkin disease with skin involvement must be 
made with caution. Hodgkin disease limited only to 
the skin has been very rarely reported (27,28), how- 
ever, and some authors doubt its existence (29,30). 
In debated cases, no immunohistochemical studies 
were performed, and probably they represented 
lymphomatoid papulosis (LP) or even ALCL (28- 
30). In addition, the marked pleomorphism, the high 
mitotic rate, and the cohesive pattern of the neo- 
plastic cells observed in our patient are not gener- 
ally observed in Hodgkin disease (19), allowing a 
diagnosis of Ki-1 ALCL. 
Lymphomatoid papulosis is also characterized 
by self-healing skin lesions, and consists of a mixed 
infiltration of in~ammatory and anaplastic Ki- 1- 
positive cells similar to those of ALCL (31-33). 
However, in LP the lesions are smaller and more 
widespread, and show epidermotropism of the ana- 
plastic cells. Those features have not been de- 
scribed in cutaneous Ki-1 ALCL. Considering the 
similarities between the disorders, and the fact that 
an association of inflammatory and neoplastic le- 
sions (as described in LP) was also observed in our 
patient, we may speculate that regressing Ki-l~ 
ALCL represents an intermediate entity between 
LP and cutaneous Ki-1 ALCL. Unfortunately, in 
the other four published cases of cutaneous regress- 
ing Ki- 1 ALCL (1 1,26) the association of inflamma- 
tory and neoplastic features was not referred to, 
possibly because only one lesion of each patient 
was examined. 
The diagnosis of this type of highly anaplastic cu- 
taneous lymphoma must be made on the basis of 
Ki-1 reactivity to distinguish it from other highly 
malignant tumors, some of them metastatic to the 
skin. Negativity to epithelial and histiocytic mark- 
ers and positivity for LCA and Ki-1 antigens make 
the diagnosis possible. One epithelial membrane an- 
tigen that is sometimes expressed by Ki-1 ALCL 
cells is EMA (10,20), but EMA was not observed in 
this patient. Also, no reactivity was observed with 
T and B cell markers. We cannot exclude the possi- 
bility that failure to demonstrate these antigens was 
the result of antigen loss due to tissue fixation and 
paraffin embedding. 
The neoplastic cells observed in our patient had 
ultrastructurally ruffled cytoplasmic membranes 
and reniform nuclear indentations, aspects that sug- 
gest histiocytic differentiation, according to Burns 
et a1 (6). However, the organelles were not promi- 
nent, lysosomes were scarce, and phagocytosis by 
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tumor cells was not observed. Fu~hermore, immu- 
nolabeling with HAM-56, a monoclonal antibody 
considered to recognize histiocytes, was negative. 
Cytoplasmic projections have been observed in 
around 20% of cases of Ki-1 ALCL (34). Microvil- 
lous lymphomas have a similar ultrast~ctural ap- 
pearance, but these tumors are Ki-1 negative (34). 
Undoubtedly, cutaneous Ki-1 ALCL has a better 
prognosis than Ki-1 ALCL of extracutaneous local- 
ization and other large cell lymphomas. The experi- 
ence with Ki-1 ALCL with self-healing tendency 
was limited to four cases, three of them associated 
with nodal involvement ( 1  1,24). All were treated 
with radiotherapy and/or chemotherapy. Those 
with nodal lesions had relapses but were alive 4 to 
30 months after diagnosis. The patient without 
nodal involvement received radiotherapy only and 
was well two years after diagnosis, with no relapse 
(24). Our patient has had no relapse four years after 
treatment, indicating a good response to chemo- 
therapy. However, as experience with cutaneous 
Ki-l ALCL with regressing lesions is limited, it is 
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